Abstract
Stimulant (e.g., cocaine, amphetamine, and methamphetamine) misuse poses a significant public health concern for adolescents given the potential impact on developmental trajectories during a period of dramatic physiological and psychological growth. High-risk behaviors already prominent in adolescents, such as violence, aggression, and unprotected sexual encounters, are also likely to increase following illicit stimulant use. This chapter provides an overview of the current primary prevention and treatment approaches targeting adolescent stimulant misuse. The history and characteristics of stimulant use and misuse, the pharmacology and clinical effects of stimulants, and expected clinical outcomes for stimulant-using adolescents are also provided. A review of the extant literature indicates that stimulant use has received little attention in the primary prevention and treatment literature when compared to adolescent alcohol, tobacco, and cannabis use. Those studies that do exist suggest that many of those prevention and treatment efforts developed for other substance use may help deter the initiation and reduce the misuse of stimulants in adolescents. Clinically useful prevention and treatment for adolescent stimulant use will likely require multiple approaches tailored to the patient and address factors at the level of the individual, peer, family, and community. More work is needed, however, to develop and test novel evidence-based methods for preventing and treating adolescent stimulant use disorder.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aktan, G. B., Kumpfer, K. L., & Turner, C. W. (1996). Effectiveness of a family skills training program for substance use prevention with inner city African-American families. Substance Use & Misuse, 31(2), 157–175.
Alexander, J. F., & Parsons, B. V. (1982). Functional family therapy: Principles and procedures. Carmel, CA: Brooks/Cole.
Alexander, M., Rothman, R. B., Baumann, M. H., Endres, C. J., Brasic, J. R., & Wong, D. F. (2005). Noradrenergic and dopaminergic effects of (+)-amphetamine-like stimulants in the baboon Papio anubis. Synapse, 56(2), 94–99. https://doi.org/10.1002/syn.20126
Allara, E., Ferri, M., Bo, A., Gasparrini, A., & Faggiano, F. (2015). Are mass-media campaigns effective in preventing drug use? A Cochrane systematic review and meta-analysis. BMJ Open, 5(9), e007449. https://doi.org/10.1136/bmjopen-2014-007449
Anderson, A. L., Li, S. H., Markova, D., Holmes, T. H., Chiang, N., Kahn, R., … Elkashef, A. M. (2015). Bupropion for the treatment of methamphetamine dependence in non-daily users: a randomized, double-blind, placebo-controlled trial. Drug and Alcohol Dependence, 150, 170–174. https://doi.org/10.1016/j.drugalcdep.2015.01.036
Anderson, D. M. (2010). Does information matter? The effect of the Meth Project on meth use among youths. Journal of Health Economicsomics, 29(5), 732–742. https://doi.org/10.1016/j.jhealeco.2010.06.005
Anderson, D. M., & Elsea, D. (2015). The Meth Project and teen meth use: New estimates from the National and State Youth Risk Behavior Surveys. Health Economics, 24(12), 1644–1650. https://doi.org/10.1002/hec.3116
Angrist, B., Corwin, J., Bartlik, B., & Cooper, T. (1987). Early pharmacokinetics and clinical effects of oral d-amphetamine in normal subjects. Biological Psychiatry, 22(11), 1357–1368.
Ary, D. V., Duncan, T. E., Biglan, A., Metzler, C. W., Noell, J. W., & Smolkowski, K. (1999). Development of adolescent problem behavior. Journal of Abnormal Child Psychology, 27(2), 141–150.
Babor, T. F., McRee, B. G., Kassebaum, P. A., Grimaldi, P. L., Ahmed, K., & Bray, J. (2007). Screening, Brief Intervention, and Referral to Treatment (SBIRT): Toward a public health approach to the management of substance abuse. Substance Abuse, 28(3), 7–30. https://doi.org/10.1300/J465v28n03_03
Baldwin, S. A., Christian, S., Berkeljon, A., & Shadish, W. R. (2012). The effects of family therapies for adolescent delinquency and substance abuse: A meta-analysis. Journal of Marital and Family Therapy, 38(1), 281–304. https://doi.org/10.1111/j.1752-0606.2011.00248.x
Belendiuk, K. A., & Riggs, P. (2014). Treatment of adolescent substance use disorders. Current Treatment Options in Psychiatry, 1(2), 175–188. https://doi.org/10.1007/s40501-014-0016-3
Berman, S. M., Kuczenski, R., McCracken, J. T., & London, E. D. (2009). Potential adverse effects of amphetamine treatment on brain and behavior: A review. Molecular Psychiatry, 14(2), 123–142. https://doi.org/10.1038/mp.2008.90
Biederman, J., Wilens, T., Mick, E., Milberger, S., Spencer, T. J., & Faraone, S. V. (1995). Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): Effects of ADHD and psychiatric comorbidity. American Journal of Psychiatry, 152(11), 1652–1658. https://doi.org/10.1176/ajp.152.11.1652
Botello-Harbaum, M. T., Haynie, D. L., Iannotti, R. J., Wang, J., Gase, L., & Simons-Morton, B. (2009). Tobacco control policy and adolescent cigarette smoking status in the United States. Nicotine & Tobacco Research, 11(7), 875–885. https://doi.org/10.1093/ntr/ntp081
Brzeczko, A. W., Leech, R., & Stark, J. G. (2013). The advent of a new pseudoephedrine product to combat methamphetamine abuse. The American Journal of Drug and Alcohol Abuse, 39(5), 284–290. https://doi.org/10.3109/00952990.2013.821476
Bukstein, O. (2008). Substance abuse in patients with attention-deficit/hyperactivity disorder. Medscape Journal of Medicine, 10(1), 24.
Callaghan, R., Taylor, L., Victor, J. C., & Lentz, T. (2007). A case-matched comparison of readmission patterns between primary methamphetamine-using and primary cocaine-using adolescents engaged in inpatient substance-abuse treatment. Addictive Behaviors, 32(12), 3101–3106. https://doi.org/10.1016/j.addbeh.2007.06.007
Callaghan, R. C., Brands, B., Taylor, L., & Lentz, T. (2007). The clinical characteristics of adolescents reporting methamphetamine as their primary drug of choice: An examination of youth admitted to inpatient substance-abuse treatment in northern British Columbia, Canada, 2001–2005. Journal of Adolescent Health, 40(3), 286–289. https://doi.org/10.1016/j.jadohealth.2006.09.025
Carney, T., Myers, B. J., Louw, J., & Okwundu, C. I. (2016). Brief school-based interventions and behavioural outcomes for substance-using adolescents. Cochrane Database of Systematic Reviews, 2016(1), 1–63. https://doi.org/10.1002/14651858.CD008969.pub3
Carroll, K. M., & Onken, L. S. (2005). Behavioral therapies for drug abuse. American Journal of Psychiatry, 162(8), 1452–1460. https://doi.org/10.1176/appi.ajp.162.8.1452
Catalano, R. F., Gainey, R. R., Fleming, C. B., Haggerty, K. P., & Johnson, N. O. (1999). An experimental intervention with families of substance abusers: one-year follow-up of the focus on families project. Addiction, 94(2), 241–254.
Cavazos-Rehg, P. A., Spitznagel, E. L., Schootman, M., Strickland, J. R., Afful, S. E., Cottler, L. B., & Bierut, L. J. (2009). Risky sexual behaviors and sexually transmitted diseases: a comparison study of cocaine-dependent individuals in treatment versus a community-matched sample. AIDS Patient Care and STDs, 23(9), 727–734. https://doi.org/10.1089/apc.2008.0272
Center for Behavioral Health Statistics and Quality. (2016). Behavioral health trends in the United States: Results from the 2015 National Survey on Drug Use and Health (HHS Publication No. SMA 15-4927, NSDUH Series H-50). Retrieved from http://www.samhsa.gov/data/
Clayton, R. R., Cattarello, A. M., & Johnstone, B. M. (1996). The effectiveness of Drug Abuse Resistance Education (project DARE): 5-year follow-up results. Preventive Medicine, 25(3), 307–318. https://doi.org/10.1006/pmed.1996.0061
Comer, S. D., Hart, C. L., Ward, A. S., Haney, M., Foltin, R. W., & Fischman, M. W. (2001). Effects of repeated oral methamphetamine administration in humans. Psychopharmacology, 155(4), 397–404.
Crowley, T. J., & Riggs, P. D. (1995). Adolescent substance use disorder with conduct disorder and comorbid conditions. NIDA Research Monographs, 156, 49–111.
Cruickshank, C. C., & Dyer, K. R. (2009). A review of the clinical pharmacology of methamphetamine. Addiction, 104(7), 1085–1099. https://doi.org/10.1111/j.1360-0443.2009.02564.x
Cunningham, K. A., & Anastasio, N. C. (2014). Serotonin at the nexus of impulsivity and cue reactivity in cocaine addiction. Neuropharmacology, 76(Pt. B), 460–478. https://doi.org/10.1016/j.neuropharm.2013.06.030
Cunningham, S., Finlay, K., & Stoecker, C. (2015). Is Mississippi’s prescription-only precursor control law a prescription to decrease the production and raise the price of methamphetamine? International Journal of Drug Policy, 26(11), 1144–1149. https://doi.org/10.1016/j.drugpo.2015.05.020
Dembo, R., Wothke, W., Livingston, S., & Schmeidler, J. (2002). The impact of a family empowerment intervention on juvenile offender heavy drinking: A latent growth model analysis. Substance Use & Misuse, 37(11), 1359–1390.
DiFranza, J. R., Savageau, J. A., & Fletcher, K. E. (2009). Enforcement of underage sales laws as a predictor of daily smoking among adolescents: A national study. BMC Public Health, 9, 107. https://doi.org/10.1186/1471-2458-9-107
Drent, M., Wijnen, P., & Bast, A. (2012). Interstitial lung damage due to cocaine abuse: Pathogenesis, pharmacogenomics and therapy. Current Medicinal Chemistry, 19(33), 5607–5611.
Dutra, L., Stathopoulou, G., Basden, S. L., Leyro, T. M., Powers, M. B., & Otto, M. W. (2008). A meta-analytic review of psychosocial interventions for substance use disorders. American Journal of Psychiatry, 165(2), 179–187. https://doi.org/10.1176/appi.ajp.2007.06111851
Dutta, S., Morton, J., Shepard, E., Peebles, R., Farrales-Nguyen, S., Hammer, L. D., & Albanese, C. T. (2006). Methamphetamine use following bariatric surgery in an adolescent. Obesity Surgery, 16(6), 780–782. https://doi.org/10.1381/096089206777346646
Elkashef, A. M., Rawson, R. A., Anderson, A. L., Li, S. H., Holmes, T., Smith, E. V., … Weis, D. (2008). Bupropion for the treatment of methamphetamine dependence. Neuropsychopharmacology, 33(5), 1162–1170. https://doi.org/10.1038/sj.npp.1301481
Elliott, J. M., & Beveridge, T. J. (2005). Psychostimulants and monoamine transporters: Upsetting the balance. Current Opinion in Pharmacology, 5(1), 94–100. https://doi.org/10.1016/j.coph.2004.09.005
Erceg-Hurn, D. M. (2008). Drugs, money, and graphic ads: A critical review of the Montana Meth Project. Prevention Science, 9(4), 256–263. https://doi.org/10.1007/s11121-008-0098-5
Faggiano, F., Minozzi, S., Versino, E., & Buscemi, D. (2014). Universal school-based prevention for illicit drug use. Cochrane Database of Systematic Reviews, 2014(12), 1–137. https://doi.org/10.1002/14651858.CD003020.pub3
Farronato, N. S., Dursteler-Macfarland, K. M., Wiesbeck, G. A., & Petitjean, S. A. (2013). A systematic review comparing cognitive-behavioral therapy and contingency management for cocaine dependence. Journal of Addictive Diseases, 32(3), 274–287. https://doi.org/10.1080/10550887.2013.824328
Ferri, M., Allara, E., Bo, A., Gasparrini, A., & Faggiano, F. (2013). Media campaigns for the prevention of illicit drug use in young people. Cochrane Database of Systematic Reviews, 2013(6), 1–97. https://doi.org/10.1002/14651858.CD009287.pub2
Foley, K. F., DeSanty, K. P., & Kast, R. E. (2006). Bupropion: Pharmacology and therapeutic applications. Expert Review of Neurotherapeutics, 6(9), 1249–1265. https://doi.org/10.1586/14737175.6.9.1249
Foltin, R. W., & Fischman, M. W. (1990). The relationship between cocaine venous blood levels and the cardiovascular and subjective effects of smoked and intravenous cocaine. NIDA Research Monographs, 105, 440–441.
Foltin, R. W., & Fischman, M. W. (1991). Smoked and intravenous cocaine in humans: Acute tolerance, cardiovascular and subjective effects. Journal of Pharmacology and Experimental Therapeutics, 257(1), 247–261.
Foltin, R. W., Fischman, M. W., Pedroso, J. J., & Pearlson, G. D. (1988). Repeated intranasal cocaine administration: Lack of tolerance to pressor effects. Drug and Alcohol Dependence, 22(3), 169–177.
Garnier, L. M., Arria, A. M., Caldeira, K. M., Vincent, K. B., O'Grady, K. E., & Wish, E. D. (2010). Sharing and selling of prescription medications in a college student sample. Journal of Clinical Psychiatry, 71(3), 262–269. https://doi.org/10.4088/JCP.09m05189ecr
Gawin, F. H. (1991). Cocaine addiction: Psychology and neurophysiology. Science, 251(5001), 1580–1586.
Gawin, F. H., & Kleber, H. D. (1985). Neuroendocrine findings in a chronic cocaine abusers: A preliminary report. British Journal of Psychiatry, 147(5), 569–573.
Glauser, J., & Queen, J. R. (2007). An overview of non-cardiac cocaine toxicity. Journal of Emergency Medicine, 32(2), 181–186. https://doi.org/10.1016/j.jemermed.2006.05.044
Godley, M. D., Godley, S. H., Dennis, M. L., Funk, R., & Passetti, L. L. (2002). Preliminary outcomes from the assertive continuing care experiment for adolescents discharged from residential treatment. Journal of Substance Abuse Treatment, 23(1), 21–32.
Gorman, D. M. (2014). Is Project Towards No Drug Abuse (Project TND) an evidence-based drug and violence prevention program? A review and reappraisal of the evaluation studies. The Journal of Primary Prevention, 35(4), 217–232. https://doi.org/10.1007/s10935-014-0348-1
Gossop, M. R., Bradley, B. P., & Brewis, R. K. (1982). Amphetamine withdrawal and sleep disturbance. Drug and Alcohol Dependence, 10(2–3), 177–183.
Grinspoon, L., & Bakalar, J. B. (1981). Coca and cocaine as medicines: An historical review. Journal of Ethnopharmacology, 3(2–3), 149–159.
Haggerty, K. P., Skinner, M., Fleming, C. B., Gainey, R. R., & Catalano, R. F. (2008). Long-term effects of the Focus on Families project on substance use disorders among children of parents in methadone treatment. Addiction, 103(12), 2008–2016. https://doi.org/10.1111/j.1360-0443.2008.02360.x
Harris, D. S., Boxenbaum, H., Everhart, E. T., Sequeira, G., Mendelson, J. E., & Jones, R. T. (2003). The bioavailability of intranasal and smoked methamphetamine. Clinical Pharmacology & Therapeutics, 74(5), 475–486. https://doi.org/10.1016/j.clpt.2003.08.002
Hart, C. L., Gunderson, E. W., Perez, A., Kirkpatrick, M. G., Thurmond, A., Comer, S. D., & Foltin, R. W. (2008). Acute physiological and behavioral effects of intranasal methamphetamine in humans. Neuropsychopharmacology, 33(8), 1847–1855. https://doi.org/10.1038/sj.npp.1301578
Hart, C. L., Ward, A. S., Haney, M., Foltin, R. W., & Fischman, M. W. (2001). Methamphetamine self-administration by humans. Psychopharmacology, 157(1), 75–81.
Havakuk, O., Rezkalla, S. H., & Kloner, R. A. (2017). The cardiovascular effects of cocaine. Journal of the American College of Cardiology, 70(1), 101–113. https://doi.org/10.1016/j.jacc.2017.05.014
Heal, D. J., Gosden, J., & Smith, S. L. (2014). Dopamine reuptake transporter (DAT) “inverse agonism”—a novel hypothesis to explain the enigmatic pharmacology of cocaine. Neuropharmacology, 87, 19–40. https://doi.org/10.1016/j.neuropharm.2014.06.012
Heinzerling, K. G., Gadzhyan, J., van Oudheusden, H., Rodriguez, F., McCracken, J., & Shoptaw, S. (2013). Pilot randomized trial of bupropion for adolescent methamphetamine abuse/dependence. Journal of Adolescent Health, 52(4), 502–505. https://doi.org/10.1016/j.jadohealth.2012.10.275
Higgins, S. T., & Petry, N. M. (1999). Contingency management. Incentives for sobriety. Alcohol Research & Health, 23(2), 122–127.
Hornik, R. (2006). Personal influence and the effects of the National Youth Anti-Drug Media Campaign. The Annals of the American Academy of Political and Social Science, 608, 282–300.
Howell, L. L., & Cunningham, K. A. (2015). Serotonin 5-HT2 receptor interactions with dopamine function: Implications for therapeutics in cocaine use disorder. Pharmacological Reviews, 67(1), 176–197. https://doi.org/10.1124/pr.114.009514
Howell, L. L., & Negus, S. S. (2014). Monoamine transporter inhibitors and substrates as treatments for stimulant abuse. Advances in Pharmacology, 69, 129–176. https://doi.org/10.1016/B978-0-12-420118-7.00004-4
Isenschmid, D. S., Fischman, M. W., Foltin, R. W., & Caplan, Y. H. (1992). Concentration of cocaine and metabolites in plasma of humans following intravenous administration and smoking of cocaine. Journal of Analytical Toxicology, 16(5), 311–314.
Jeffcoat, A. R., Perez-Reyes, M., Hill, J. M., Sadler, B. M., & Cook, C. E. (1989). Cocaine disposition in humans after intravenous injection, nasal insufflation (snorting), or smoking. Drug Metabolism & Disposition, 17(2), 153–159.
Jensen, C. D., Cushing, C. C., Aylward, B. S., Craig, J. T., Sorell, D. M., & Steele, R. G. (2011). Effectiveness of motivational interviewing interventions for adolescent substance use behavior change: A meta-analytic review. Journal of Consulting and Clinical Psychology, 79(4), 433–440. https://doi.org/10.1037/a0023992
Jessor, R., & Jessor, S. L. (1977). Problem behavior and psychosocial development: A longitudinal study of youth. New York, NY: Academic Press.
Johnson, C. A., Pentz, M. A., Weber, M. D., Dwyer, J. H., Baer, N., MacKinnon, D. P., … Flay, B. R. (1990). Relative effectiveness of comprehensive community programming for drug abuse prevention with high-risk and low-risk adolescents. Journal of Consulting and Clinical Psychology, 58(4), 447–456.
Johnston, L. D., O’Malley, P. M., Miech, R. A., Bachman, J. G., & Schulenberg, J. E. (2017). Monitoring the Future national survey results on drug use, 1975–2016: Overview, key findings on adolescent drug use. Ann Arbor, MI: Institute for Social Research, The University of Michigan.
Kerr, T., Small, W., & Wood, E. (2005). The public health and social impacts of drug market enforcement: A review of the evidence. International Journal of Drug Policy, 16(4), 210–220.
Kirkpatrick, M. G., Gunderson, E. W., Johanson, C. E., Levin, F. R., Foltin, R. W., & Hart, C. L. (2012). Comparison of intranasal methamphetamine and d-amphetamine self-administration by humans. Addiction, 107(4), 783–791. https://doi.org/10.1111/j.1360-0443.2011.03706.x
Knight, J. R., Sherritt, L., Harris, S. K., Gates, E. C., & Chang, G. (2003). Validity of brief alcohol screening tests among adolescents: A comparison of the AUDIT, POSIT, CAGE, and CRAFFT. Alcoholism: Clinical and Experimental Research, 27(1), 67–73. https://doi.org/10.1097/01.ALC.0000046598.59317.3A
Knight, J. R., Sherritt, L., Shrier, L. A., Harris, S. K., & Chang, G. (2002). Validity of the CRAFFT substance abuse screening test among adolescent clinic patients. Archives of Pediatrics & Adolescent Medicine, 156(6), 607–614.
Knight, J. R., Shrier, L. A., Bravender, T. D., Farrell, M., Vander Bilt, J., & Shaffer, H. J. (1999). A new brief screen for adolescent substance abuse. Archives of Pediatrics & Adolescent Medicine, 153(6), 591–596.
Kumpfer, K. L., Alvarado, R., & Whiteside, H. O. (2003). Family-based interventions for substance use and misuse prevention. Substance Use & Misuse, 38(11–13), 1759–1787.
Lee, N. K., & Rawson, R. A. (2008). A systematic review of cognitive and behavioural therapies for methamphetamine dependence. Drug and Alcohol Review, 27(3), 309–317. https://doi.org/10.1080/09595230801919494
Lewit, E. M., Hyland, A., Kerrebrock, N., & Cummings, K. M. (1997). Price, public policy, and smoking in young people. Tobacco Control, 6(Suppl 2), S17–S24.
Liddle, H. A., Rowe, C. L., Dakof, G. A., Henderson, C. E., & Greenbaum, P. E. (2009). Multidimensional family therapy for young adolescent substance abuse: Twelve-month outcomes of a randomized controlled trial. Journal of Consulting and Clinical Psychology, 77(1), 12–25. https://doi.org/10.1037/a0014160
Lindstrom, M., Filges, T., & Jorgensen, A. M. K. (2015). Brief strategic family therapy for young people in treatment for drug use. Research on Social Work Practice, 25(1), 61–80.
Lott, D. C., & Jencius, S. (2009). Effectiveness of very low-cost contingency management in a community adolescent treatment program. Drug and Alcohol Dependence, 102(1–3), 162–165. https://doi.org/10.1016/j.drugalcdep.2009.01.010
Lynam, D. R., Milich, R., Zimmerman, R., Novak, S. P., Logan, T. K., Martin, C., … Clayton, R. (1999). Project DARE: No effects at 10-year follow-up. Journal of Consulting and Clinical Psychology, 67(4), 590–593.
Lyoo, I. K., Yoon, S., Kim, T. S., Lim, S. M., Choi, Y., Kim, J. E., … Renshaw, P. F. (2015). Predisposition to and effects of methamphetamine use on the adolescent brain. Molecular Psychiatry, 20(12), 1516–1524. https://doi.org/10.1038/mp.2014.191
Madras, B. K., Compton, W. M., Avula, D., Stegbauer, T., Stein, J. B., & Clark, H. W. (2009). Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: Comparison at intake and 6 months later. Drug and Alcohol Dependence, 99(1–3), 280–295. https://doi.org/10.1016/j.drugalcdep.2008.08.003
Marks, K. R., Lile, J. A., Stoops, W. W., Glaser, P. E., Hays, L. R., & Rush, C. R. (2016). Separate and combined effects of naltrexone and extended-release alprazolam on the reinforcing, subject-rated, and cardiovascular effects of methamphetamine. Journal of Clinical Psychopharmacology, 36(3), 213–221. https://doi.org/10.1097/JCP.0000000000000488
Marsden, J., Stillwell, G., Barlow, H., Boys, A., Taylor, C., Hunt, N., & Farrell, M. (2006). An evaluation of a brief motivational intervention among young ecstasy and cocaine users: No effect on substance and alcohol use outcomes. Addiction, 101(7), 1014–1026. https://doi.org/10.1111/j.1360-0443.2006.01290.x
Marsh, W., Copes, H., & Linnemann, T. (2017). Creating visual differences: Methamphetamine users perceptions of anti-meth campaigns. International Journal of Drug Policy, 39, 52–61. https://doi.org/10.1016/j.drugpo.2016.09.001
McCabe, S. E., Teter, C. J., & Boyd, C. J. (2004). The use, misuse and diversion of prescription stimulants among middle and high school students. Substance Use & Misuse, 39(7), 1095–1116.
McCabe, S. E., West, B. T., Teter, C. J., & Boyd, C. J. (2014). Trends in medical use, diversion, and nonmedical use of prescription medications among college students from 2003 to 2013: Connecting the dots. Addictive Behaviors, 39(7), 1176–1182. https://doi.org/10.1016/j.addbeh.2014.03.008
McCabe, S. E., West, B. T., Teter, C. J., Cranford, J. A., Ross-Durow, P. L., & Boyd, C. J. (2012). Adolescent nonmedical users of prescription opioids: Brief screening and substance use disorders. Addictive Behaviors, 37(5), 651–656. https://doi.org/10.1016/j.addbeh.2012.01.021
McCartt, A. T., Hellinga, L. A., & Kirley, B. B. (2010). The effects of minimum legal drinking age 21 laws on alcohol-related driving in the United States. Journal of Safety Research, 41(2), 173–181. https://doi.org/10.1016/j.jsr.2010.01.002
McGregor, C., Srisurapanont, M., Jittiwutikarn, J., Laobhripatr, S., Wongtan, T., & White, J. M. (2005). The nature, time course and severity of methamphetamine withdrawal. Addiction, 100(9), 1320–1329. https://doi.org/10.1111/j.1360-0443.2005.01160.x
Mendelson, J., Uemura, N., Harris, D., Nath, R. P., Fernandez, E., Jacob, P., 3rd, … Jones, R. T. (2006). Human pharmacology of the methamphetamine stereoisomers. Clinical Pharmacology & Therapeutics, 80(4), 403–420. https://doi.org/10.1016/j.clpt.2006.06.013
Miller, W. R., & Rollnick, S. (1991). Motivational interviewing: Preparing people to change addictive behavior. New York, NY: Guilford Press.
Mitchell, S. G., Gryczynski, J., Gonzales, A., Moseley, A., Peterson, T., O'Grady, K. E., & Schwartz, R. P. (2012). Screening, brief intervention, and referral to treatment (SBIRT) for substance use in a school-based program: Services and outcomes. The American Journal on Addictions, 21(Suppl 1), S5–S13. https://doi.org/10.1111/j.1521-0391.2012.00299.x
Mitchell, S. G., Gryczynski, J., O’Grady, K. E., & Schwartz, R. P. (2013). SBIRT for adolescent drug and alcohol use: Current status and future directions. Journal of Substance Abuse Treatment, 44(5), 463–472. https://doi.org/10.1016/j.jsat.2012.11.005
Mitchell, S. G., Kelly, S. M., Gryczynski, J., Myers, C. P., O'Grady, K. E., Kirk, A. S., & Schwartz, R. P. (2014). The CRAFFT cut-points and DSM-5 criteria for alcohol and other drugs: A reevaluation and reexamination. Substance Abuse, 35(4), 376–380. https://doi.org/10.1080/08897077.2014.936992
Mone, S. M., Gillman, M. W., Miller, T. L., Herman, E. H., & Lipshultz, S. E. (2004). Effects of environmental exposures on the cardiovascular system: Prenatal period through adolescence. Pediatrics, 113(4 Suppl), 1058–1069.
Müller, C. P., Carey, R. J., Huston, J. P., & De Souza Silva, M. A. (2007). Serotonin and psychostimulant addiction: Focus on 5-HT1A-receptors. Progress in Neurobiology, 81(3), 133–178. https://doi.org/10.1016/j.pneurobio.2007.01.001
Neale, A., Abraham, S., & Russell, J. (2009). “Ice” use and eating disorders: A report of three cases. International Journal of Eating Disorders, 42(2), 188–191. https://doi.org/10.1002/eat.20587
Newton, T. F., De La Garza, R., II, Kalechstein, A. D., & Nestor, L. (2005). Cocaine and methamphetamine produce different patterns of subjective and cardiovascular effects. Pharmacology Biochemistry and Behavior, 82(1), 90–97. https://doi.org/10.1016/j.pbb.2005.07.012
Nutt, D. J., Lingford-Hughes, A., Erritzoe, D., & Stokes, P. R. (2015). The dopamine theory of addiction: 40 years of highs and lows. Nature Reviews Neuroscience, 16(5), 305–312. https://doi.org/10.1038/nrn3939
Oesterle, T. S., Hitschfeld, M. J., Lineberry, T. W., & Schneekloth, T. D. (2015). CRAFFT as a substance use screening instrument for adolescent psychiatry admissions. Journal of Psychiatric Practice, 21(4), 259–266. https://doi.org/10.1097/PRA.0000000000000083
Ozechowski, T. J., Becker, S. J., & Hogue, A. (2016). SBIRT-A: Adapting SBIRT to maximize developmental fit for adolescents in primary care. Journal of Substance Abuse Treatment, 62, 28–37. https://doi.org/10.1016/j.jsat.2015.10.006
Paglia, A., & Room, R. (1999). Preventing substance use problems among youth: A literature review and recommendations. The Journal of Primary Prevention, 20, 3–50.
Pan, W., & Bai, H. (2009). A multivariate approach to a meta-analytic review of the effectiveness of the D.A.R.E. program. International Journal of Environmental Research and Public Health, 6(1), 267–277. https://doi.org/10.3390/ijerph6010267
Park, J., Kosterman, R., Hawkins, J. D., Haggerty, K. P., Duncan, T. E., Duncan, S. C., & Spoth, R. (2000). Effects of the “Preparing for the Drug Free Years” curriculum on growth in alcohol use and risk for alcohol use in early adolescence. Prevention Science, 1(3), 125–138.
Pasic, J., Russo, J. E., Ries, R. K., & Roy-Byrne, P. P. (2007). Methamphetamine users in the psychiatric emergency services: A case-control study. The American Journal of Drug and Alcohol Abuse, 33(5), 675–686. https://doi.org/10.1080/00952990701522732
Pentz, M. A., Dwyer, J. H., MacKinnon, D. P., Flay, B. R., Hansen, W. B., Wang, E. Y., & Johnson, C. A. (1989). A multicommunity trial for primary prevention of adolescent drug abuse. Effects on drug use prevalence. Journal of the American Medical Association, 261(22), 3259–3266.
Perry, C. L., Komro, K. A., Veblen-Mortenson, S., Bosma, L. M., Farbakhsh, K., Munson, K. A., … Lytle, L. A. (2003). A randomized controlled trial of the middle and junior high school D.A.R.E. and D.A.R.E. Plus programs. Archives of Pediatrics & Adolescent Medicine, 157(2), 178–184.
Pianca, T. G., Rosa, R. L., Cereser, K. M. M., de Aguiar, B. W., de Abrahao, R. C., Lazzari, P. M., … Szobot, C. M. (2017). Differences in biomarkers of crack-cocaine adolescent users before/after abstinence. Drug and Alcohol Dependence, 177, 207–213. https://doi.org/10.1016/j.drugalcdep.2017.03.043
Pilowsky, D. J., & Wu, L. T. (2013). Screening instruments for substance use and brief interventions targeting adolescents in primary care: A literature review. Addictive Behaviors, 38(5), 2146–2153. https://doi.org/10.1016/j.addbeh.2013.01.015
Prendergast, M., Podus, D., Finney, J., Greenwell, L., & Roll, J. (2006). Contingency management for treatment of substance use disorders: A meta-analysis. Addiction, 101(11), 1546–1560. https://doi.org/10.1111/j.1360-0443.2006.01581.x
Radcliffe, P., & Stevens, A. (2008). Are drug treatment services only for ‘thieving junkie scumbags’? Drug users and the management of stigmatized identities. Social Science & Medicine, 67(7), 1065–1073.
Rawson, R. A., Gonzales, R., McCann, M., & Ling, W. (2007). Use of methamphetamine by young people: Is there reason for concern? Addiction, 102(7), 1021–1022. https://doi.org/10.1111/j.1360-0443.2007.01899.x
Rawson, R. A., Gonzales, R., Obert, J. L., McCann, M. J., & Brethen, P. (2005). Methamphetamine use among treatment-seeking adolescents in Southern California: Participant characteristics and treatment response. Journal of Substance Abuse Treatment, 29(2), 67–74. https://doi.org/10.1016/j.jsat.2005.04.001
Riggs, N. R., Chou, C. P., & Pentz, M. A. (2009). Preventing growth in amphetamine use: Long-term effects of the Midwestern Prevention Project (MPP) from early adolescence to early adulthood. Addiction, 104(10), 1691–1699. https://doi.org/10.1111/j.1360-0443.2009.02666.x
Riggs, P. D., Leon, S. L., Mikulich, S. K., & Pottle, L. C. (1998). An open trial of bupropion for ADHD in adolescents with substance use disorders and conduct disorder. The American Academy of Child and Adolescent Psychiatry, 37(12), 1271–1278. https://doi.org/10.1097/00004583-199812000-00010
Riggs, P. D., Winhusen, T., Davies, R. D., Leimberger, J. D., Mikulich-Gilbertson, S., Klein, C., … Liu, D. (2011). Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with attention-deficit/hyperactivity disorder and substance use disorders. The American Academy of Child and Adolescent Psychiatry, 50(9), 903–914. https://doi.org/10.1016/j.jaac.2011.06.010
Rocha, B. A. (2003). Stimulant and reinforcing effects of cocaine in monoamine transporter knockout mice. European Journal of Pharmacology, 479(1–3), 107–115.
Rodner, S. (2005). “I am not a drug abuse, I am a drug user”: A discourse analysis of 44 drug users’ construction of identity. Addiction Research and Therapy, 13(4), 333–346.
Rohrbach, L. A., Sun, P., & Sussman, S. (2010). One-year follow-up evaluation of the Project Towards No Drug Abuse (TND) dissemination trial. Preventive Medicine, 51(3–4), 313–319. https://doi.org/10.1016/j.ypmed.2010.07.016
Rothman, R. B., & Baumann, M. H. (2003). Monoamine transporters and psychostimulant drugs. European Journal of Pharmacology, 479(1–3), 23–40.
Rothman, R. B., Baumann, M. H., Dersch, C. M., Romero, D. V., Rice, K. C., Carroll, F. I., & Partilla, J. S. (2001). Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse, 39(1), 32–41. https://doi.org/10.1002/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3
Rowe, C. L. (2012). Family therapy for drug abuse: review and updates 2003–2010. Journal of Marital and Family Therapy, 38(1), 59–81. https://doi.org/10.1111/j.1752-0606.2011.00280.x
Rush, C. R., Baker, R. W., & Wright, K. (1999). Acute physiological and behavioral effects of oral cocaine in humans: A dose-response analysis. Drug and Alcohol Dependence, 55(1–2), 1–12.
Rush, C. R., Kollins, S. H., & Pazzaglia, P. J. (1998). Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in d-amphetamine-trained humans. Experimental and Clinical Psychopharmacology, 6(1), 32–44.
Santisteban, D. A., Mena, M. P., & McCabe, B. E. (2011). Preliminary results for an adaptive family treatment for drug abuse in Hispanic youth. Journal of Family Psychology, 25(4), 610–614. https://doi.org/10.1037/a0024016
Scheier, L. M., & Grenard, J. L. (2010). Influence of a nationwide social marketing campaign on adolescent drug use. Journal of Health Communication, 15(3), 240–271. https://doi.org/10.1080/10810731003686580
Shoptaw, S. J., Heinzerling, K. G., Rotheram-Fuller, E., Steward, T., Wang, J., Swanson, A. N., … Ling, W. (2008). Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence. Drug and Alcohol Dependence, 96(3), 222–232. https://doi.org/10.1016/j.drugalcdep.2008.03.010
Shoptaw, S. J., Kao, U., Heinzerling, K., & Ling, W. (2009). Treatment for amphetamine withdrawal. Cochrane Database of Systematic Reviews, 2009(2), 1–22. https://doi.org/10.1002/14651858.CD003021.pub2
Shoptaw, S. J., King, W. D., Landstrom, E., Bholat, M. A., Heinzerling, K., Victorianne, G. D., & Roll, J. M. (2009). Public health issues surrounding methamphetamine dependence. In J. R. Roll, W. Ling, R. A. Rawson, & S. Shoptaw (Eds.), Methamphetamine addiction: Basic science to treatment (pp. 143–156). New York, NY: Guilford Press.
Shoptaw, S. J., Klausner, J. D., Reback, C. J., Tierney, S., Stansell, J., Hare, C. B., … Dang, J. (2006). A public health response to the methamphetamine epidemic: The implementation of contingency management to treat methamphetamine dependence. BMC Public Health, 6, 214. https://doi.org/10.1186/1471-2458-6-214
Shukla, R. K., Crump, J. L., & Chrisco, E. S. (2012). An evolving problem: Methamphetamine production and trafficking in the United States. International Journal of Drug Policy, 23(6), 426–435. https://doi.org/10.1016/j.drugpo.2012.07.004
Siebel, T. M., & Mange, S. A. (2009). The Montana Meth Project: “Unselling” a dangerous drug. Stanford Law & Policy Review, 20, 405–416.
Simon, S. L., Richardson, K., Dacey, J., Glynn, S., Domier, C. P., Rawson, R. A., & Ling, W. (2002). A comparison of patterns of methamphetamine and cocaine use. Journal of Addictive Diseases, 21(1), 35–44.
Sofuoglu, M., & Sewell, R. A. (2009). Norepinephrine and stimulant addiction. Addiction Biology, 14(2), 119–129. https://doi.org/10.1111/j.1369-1600.2008.00138.x
Solhkhah, R., Wilens, T. E., Daly, J., Prince, J. B., Van Patten, S. L., & Biederman, J. (2005). Bupropion SR for the treatment of substance-abusing outpatient adolescents with attention-deficit/hyperactivity disorder and mood disorders. Journal of Child and Adolescent Psychopharmacology, 15(5), 777–786. https://doi.org/10.1089/cap.2005.15.777
Stanger, C., Lansing, A. H., & Budney, A. J. (2016). Advances in research on contingency management for adolescent substance use. Child & Adolescent Psychiatric Clinics of North America, 25(4), 645–659. https://doi.org/10.1016/j.chc.2016.05.002
Stein, M. D. (1999). Medical consequences of substance abuse. Psychiatric Clinics of North America, 22(2), 351–370.
Sterling, S., Kline-Simon, A. H., Satre, D. D., Jones, A., Mertens, J., Wong, A., & Weisner, C. (2015). Implementation of screening, brief intervention, and referral to treatment for adolescents in pediatric primary care: A cluster randomized trial. JAMA Pediatrics, 169(11), e153145. https://doi.org/10.1001/jamapediatrics.2015.3145
Stitzer, M., & Petry, N. (2006). Contingency management for treatment of substance abuse. Annual Review of Clinical Psychology, 2, 411–434. https://doi.org/10.1146/annurev.clinpsy.2.022305.095219
Stoops, W. W., Glaser, P. E., Fillmore, M. T., & Rush, C. R. (2004). Reinforcing, subject-rated, performance and physiological effects of methylphenidate and d-amphetamine in stimulant abusing humans. Journal of Psychopharmacology, 18(4), 534–543. https://doi.org/10.1177/0269881104047281
Stoops, W. W., Pike, E., Hays, L. R., Glaser, P. E., & Rush, C. R. (2015). Naltrexone and bupropion, alone or combined, do not alter the reinforcing effects of intranasal methamphetamine. Pharmacology Biochemistry and Behavior, 129, 45–50. https://doi.org/10.1016/j.pbb.2014.11.018
Strang, J., Babor, T., Caulkins, J., Fischer, B., Foxcroft, D., & Humphreys, K. (2012). Drug policy and the public good: Evidence for effective interventions. Lancet, 379(9810), 71–83. https://doi.org/10.1016/S0140-6736(11)61674-7
Sun, W., Skara, S., Sun, P., Dent, C. W., & Sussman, S. (2006). Project Towards No Drug Abuse: Long-term substance use outcomes evaluation. Preventive Medicine, 42(3), 188–192. https://doi.org/10.1016/j.ypmed.2005.11.011
Susskind, H., Weber, D. A., Volkow, N. D., & Hitzemann, R. (1991). Increased lung permeability following long-term use of free-base cocaine (crack). Chest, 100(4), 903–909.
Sussman, S., Valente, T. W., Rohrbach, L. A., Dent, C. W., & Sun, P. (2014). Commentary—Project Towards No Drug Abuse: An evidence-based drug abuse prevention program. The Journal of Primary Prevention, 35(4), 233–237. https://doi.org/10.1007/s10935-014-0353-4
Swadi, H. (1999). Individual risk factors for adolescent substance use. Drug and Alcohol Dependence, 55(3), 209–224.
Szobot, C. M., Rohde, L. A., Katz, B., Ruaro, P., Schaefer, T., Walcher, M., … Pechansky, F. (2008). A randomized crossover clinical study showing that methylphenidate-SODAS improves attention-deficit/hyperactivity disorder symptoms in adolescents with substance use disorder. Brazilian Journal of Medical and Biological Research, 41(3), 250–257.
Tashkin, D. P., Khalsa, M. E., Gorelick, D., Chang, P., Simmons, M. S., Coulson, A. H., & Gong, H., Jr. (1992). Pulmonary status of habitual cocaine smokers. The American Review of Respiratory Disease, 145(1), 92–100. https://doi.org/10.1164/ajrccm/145.1.92
Teter, C. J., McCabe, S. E., Cranford, J. A., Boyd, C. J., & Guthrie, S. K. (2005). Prevalence and motives for illicit use of prescription stimulants in an undergraduate student sample. Journal of American College Health, 53(6), 253–262. https://doi.org/10.3200/JACH.53.6.253-262
Thomas, R. E., McLellan, J., & Perera, R. (2013). School-based programs for preventing smoking. Cochrane Database of Systematic Reviews, 2013(4), 1–331. https://doi.org/10.1002/14651858.CD001293.pub3
Tobler, N. S., Roona, M. R., Ochshorn, P., Marshall, D. G., Streke, A. V., & Stackpole, K. M. (2000). School-based adolescent drug prevention, 2 programs: 1998 meta-analysis. The Journal of Primary Prevention, 20(4), 275–336.
Uhl, G. R., Hall, F. S., & Sora, I. (2002). Cocaine, reward, movement and monoamine transporters. Molecular Psychiatry, 7(1), 21–26. https://doi.org/10.1038/sj/mp/4000964
Upadhyaya, H. P. (2008). Substance use disorders in children and adolescents with attention-deficit/hyperactivity disorder: Implications for treatment and the role of the primary care physician. Prim Care Companion Journal of Clinical Psychiatry, 10(3), 211–221.
Valencia, M. P., & Castillo, M. (2008). Congenital and acquired lesions of the nasal septum: A practical guide for differential diagnosis. Radiographics, 28(1), 205–224.; quiz 326. https://doi.org/10.1148/rg.281075049
Vermeulen-Smit, E., Verdurmen, J. E., & Engels, R. C. (2015). The effectiveness of family interventions in preventing adolescent illicit drug use: A systematic review and meta-analysis of randomized controlled trials. Clinical Child and Family Psychology Review, 18(3), 218–239. https://doi.org/10.1007/s10567-015-0185-7
Voas, R. B., Tippetts, A. S., & Fell, J. C. (2003). Assessing the effectiveness of minimum legal drinking age and zero tolerance laws in the United States. Accident Analysis & Prevention, 35(4), 579–587.
Volkow, N. D., Wang, G. J., Fischman, M. W., Foltin, R., Fowler, J. S., Franceschi, D., … Pappas, N. (2000). Effects of route of administration on cocaine induced dopamine transporter blockade in the human brain. Life Sciences, 67(12), 1507–1515.
Vrecko, S. (2015). Everyday drug diversions: A qualitative study of the illicit exchange and non-medical use of prescription stimulants on a university campus. Social Science & Medicine, 131, 297–304. https://doi.org/10.1016/j.socscimed.2014.10.016
Waldron, H. B., & Turner, C. W. (2008). Evidence-based psychosocial treatments for adolescent substance abuse. Journal of Clinical Child & Adolescent Psychology, 37(1), 238–261. https://doi.org/10.1080/15374410701820133
Ward, A. S., Haney, M., Fischman, M. W., & Foltin, R. W. (1997). Binge cocaine self-administration by humans: Smoked cocaine. Behavioural Pharmacology, 8(8), 736–744.
Warden, D., Riggs, P. D., Min, S. J., Mikulich-Gilbertson, S. K., Tamm, L., Trello-Rishel, K., & Winhusen, T. (2012). Major depression and treatment response in adolescents with ADHD and substance use disorder. Drug and Alcohol Dependence, 120(1–3), 214–219. https://doi.org/10.1016/j.drugalcdep.2011.08.001
Wee, S., Anderson, K. G., Baumann, M. H., Rothman, R. B., Blough, B. E., & Woolverton, W. L. (2005). Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogs. Journal of Pharmacology and Experimental Therapeutics, 313(2), 848–854. https://doi.org/10.1124/jpet.104.080101
Weinshenker, D., & Schroeder, J. P. (2007). There and back again: A tale of norepinephrine and drug addiction. Neuropsychopharmacology, 32(7), 1433–1451. https://doi.org/10.1038/sj.npp.1301263
Wells, S. M., Buford, M. C., Porter, V. M., Brunell, H. L., Bunderson-Schelvan, M., Nevin, A. B., … Holian, A. (2010). Role of the serotonergic system in reduced pulmonary function after exposure to methamphetamine. American Journal of Respiratory Cell and Molecular Biology, 42(5), 537–544. https://doi.org/10.1165/rcmb.2009-0121OC
Werb, D., Rowell, G., Guyatt, G., Kerr, T., Montaner, J., & Wood, E. (2011). Effect of drug law enforcement on drug market violence: a systematic review. International Journal of Drug Policy, 22(2), 87–94. https://doi.org/10.1016/j.drugpo.2011.02.002
West, S. L., & O’Neal, K. K. (2004). Project D.A.R.E. outcome effectiveness revisited. American Journal of Public Health, 94(6), 1027–1029.
Wilens, T. E., Adler, L. A., Adams, J., Sgambati, S., Rotrosen, J., Sawtelle, R., … Fusillo, S. (2008). Misuse and diversion of stimulants prescribed for ADHD: A systematic review of the literature. The American Academy of Child and Adolescent Psychiatry, 47(1), 21–31. https://doi.org/10.1097/chi.0b013e31815a56f1
Wise, R. A., & Bozarth, M. A. (1987). A psychomotor stimulant theory of addiction. Psychological Review, 94(4), 469–492.
Wu, Y., Stanton, B. F., Galbraith, J., Kaljee, L., Cottrell, L., Li, X., … Burns, J. M. (2003). Sustaining and broadening intervention impact: A longitudinal randomized trial of 3 adolescent risk reduction approaches. Pediatrics, 111(1), e32–e38.
Yu, C. H., Guarna, G., Tsao, P., Jesuthasan, J. R., Lau, A. N., Siddiqi, F. S., … Advani, A. (2016). Incentivizing health care behaviors in emerging adults: A systematic review. Patient Preference and Adherence, 10, 371–381. https://doi.org/10.2147/PPA.S102574
Zaso, M. J., Park, A., & Antshel, K. M. (2015). Treatments for adolescents with comorbid ADHD and substance use disorder: A systematic review. Journal of Attention Disorders. Advance online publication. https://doi.org/10.1177/1087054715569280
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media LLC
About this chapter
Cite this chapter
Strickland, J.C., Stoops, W.W. (2018). The Prevention and Treatment of Adolescent Stimulant and Methamphetamine Use. In: Leukefeld, C., Gullotta, T. (eds) Adolescent Substance Abuse. Issues in Children's and Families' Lives. Springer, Cham. https://doi.org/10.1007/978-3-319-90611-9_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-90611-9_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-90610-2
Online ISBN: 978-3-319-90611-9
eBook Packages: Behavioral Science and PsychologyBehavioral Science and Psychology (R0)